ACRS (Aclaris Therapeutics Inc.) Sof foyda

ACRS (Aclaris Therapeutics, Inc.) - kompaniyaning tovar belgisi

Aclaris Therapeutics (ACRS) kompaniyasining kunlik narxlar grafigi, garchi yakuniy testlar tibbiy nazoratni talab qilsa-da, sintezni avtomatlashtirishda molekulalarni tezkor tanlash uchun AI texnologiyasini joriy etayotgan kompaniyaning dinamikasini aks ettiradi. Biznes modeli dastlabki bosqichdagi tadqiqotlarni tashqi pudratchilarga autsorsing qilishga asoslangan bo'lib, bu ishlab chiqarishdagi uzilishlarni kamaytiradi. Joriy ko'rsatkich -0.08 darajasida bo'lib, bu organizmning himoya funksiyalarini kuchaytirish uchun mo'ljallangan innovatsion agentlar ishlab chiquvchisi sifatidagi maqomini tasdiqlaydi.

ACRS (Aclaris Therapeutics) Sof foyda tarixi 04.07.2022dan 01.11.2026gacha

Aclaris Therapeutics, Inc. (ACRS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Aclaris Therapeutics, Inc|ACRS - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Aclaris Therapeutics, Inc|ACRS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Aclaris Therapeutics|ACRS - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi aclaristx.com|ACRS - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Aclaris Therapeutics|ACRS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Aclaris Therapeutics Inc.|ACRS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Aclaris Therapeutics, Inc|ACRS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Aclaris Therapeutics|Shoshilinch likvidlik aclaristx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ACRS - Sof foyda
Kompaniyaning jamlanma tahlili:Aclaris Therapeutics
Aclaris asosiy tovari

Institutsional aktivlarni tanlash emitentning kritik rentabellik darajalarini saqlab qolish qobiliyatiga asoslanadi. Ushbu metrika sof foyda tebranishlarini va operatsion samaradorlikning me'yordan og'ishini o'lchaydi. Aclaris Therapeutics (ACRS) uchun foyda hisob-kitoblari bevosita klinik sinovlarning muvaffaqiyatiga va molekulalarning patent himoyasiga bog'liq. GURU.Markets tahlillari kompaniyaning moliyaviy foydasi dinamikasi orqali aktivlarning qiymati pasayishi xavfini baholash imkonini beradi. O'sish tendentsiyasi biotexnologik ishlanmalarning tijorat jihatidan hayotiy ekanligini tasdiqlaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|NKTR: Sof foyda|Sof daromad upstreambio.com|Kompaniyaning sof foydasi Zenas Biopharma|Kompaniyaning sof foydasi IMNM|Sof foyda GOSS|Sof foyda KalVista Corp (KALV)|Kompaniyaning sof foydasi Septerna Inc SEPN|Yakuniy foyda PVLA|Savara - Sof foyda|Sof moliyaviy natija Rigel Pharma RIGL|AnaptysBio Corp (ANAB) - Kompaniyaning sof foydasi|ATXS - Sof moliyaviy natija|Sof daromad ENGN|RAPT: Yakuniy foyda|Sof daromad JBIO (Aerovate Therapeutics Inc)|Soliqlar to‘langandan keyingi foyda KYTX|Sof foyda TLSA (Tiziana Life Sciences PLC)|Yakuniy foyda CABA|Ventyx Biosciences - Sof foyda|Kompaniyaning sof daromadi theratech.com|Avalo Therapeutics (AVTX) - Kompaniyaning sof foydasi|Eledon Pharmaceuticals Inc. - Yakuniy foyda|AGEN (Agenus Inc) - Sof foyda|Sof foyda Climb Bio, Inc|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|ATYR: Soliqdan keyingi foyda|Sof foyda ADAG (Adagene Inc.)|ImageneBio (IMA) - Kompaniyaning sof daromadi|STTK: Sof daromad|EQ - Sof foyda|CNTB (connectbiopharm.com) - Sof daromad|IMUX: Soliqlar to‘langandan keyingi foyda|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|InflaRx GmbH (IFRX) - Sof moliyaviy natija|Sof foyda XFOR|Sof daromad adicetbio.com ACET|Kompaniyaning sof foydasi Celularity CELU|Sof moliyaviy natija inmunebio.com (INMB)|Barinthus Biotherapeutics plc - Sof foyda|KZR - Sof foyda|SABS: Sof foyda|Sof daromad Akari Therapeutics, Plc|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|QTTB: Yakuniy foyda|Kompaniyaning sof foydasi GeoVax (GOVX)|Sof moliyaviy natija Edesa Biotech Inc|Kompaniyaning sof foydasi iBio Corp IBIO|CARM (Carisma Therapeutics Inc) - Soliqdan keyingi foyda|XTL Biopharmaceuticals - Sof foyda|Yakuniy foyda BOLT (Bolt Biotherapeutics)|HCWB: Sof foyda|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Kompaniyaning sof foydasi AIM ImmunoTech|ADTX: Yakuniy foyda|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof daromad xortx.com XRTX|Sof foyda HIND (Vyome Holdings)|Sof foyda Revelation Biosciences Inc REVB|INDP: Sof daromad|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|AFMD - Sof moliyaviy natija|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Ocean Biomedical, Inc. - Sof daromad|Sof foyda tcbiopharm.com TCBP|THRD - Kompaniyaning sof foydasi